✦ LIBER ✦

Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma

✍ Scribed by R.E.S. El-Galley; J.A. Petros; W.H. Sanders; T.E. Keane; N.T.M. Galloway; W.H. Cooner; Sam D. Graham Jr.

Book ID: 119487869
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 549 KB
Volume: 46
Category: Article
ISSN: 0090-4295
DOI: 10.1016/s0090-4295(99)80194-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: Age Adjusted Prostate Specific Antig

Re: Age Adjusted Prostate Specific Antigen and Prostate Specific Antigen Velocity Cut Points in Prostate Cancer Screening

✍ Samir S. Taneja 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Evaluation of age-specific normal ranges

Evaluation of age-specific normal ranges for prostate-specific antigen

✍ V.O. Speights Jr.; Peter N. Brawn; Donald M. Foster; A. Michael Spiekerman; Dan 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 499 KB

Role of prostate-specific antigen densit

Role of prostate-specific antigen density after applying age-specific prostate-specific antigen reference ranges

✍ Alaa W. Meshref; Michel Bazinet; Claude Trudel; Samuel Aronson; Francois Peloqui 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 855 KB

Prostate cancer, screening, and prostate

Prostate cancer, screening, and prostate-specific antigen

✍ John D. Voss 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 776 KB

Role of Free Prostate-Specific Antigen M

Role of Free Prostate-Specific Antigen Measurement in Prostate-Specific Antigen Screening for Prostate Cancer

✍ Johnson, Lori; Sartor, Oliver; Moul, Judd W.; Klein, Eric A. 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 121 KB

Prostate-specific antigen in screening o

Prostate-specific antigen in screening of prostate cancer

✍ Dr. T. Ming Chu 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB 👁 1 views

Prostate-specific antigen (PSA) is a wellcharacterized human prostate-specific glycoprotein. PSA has been shown to be the most effective immunohistologic marker for prostate cancer, as well as the most useful serologic test in staging and monitoring prostate cancer and in early detection of recurren